Michel Dahan Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Michel Dahan.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Michel Dahan. Michel Dahan is a SVP, Chief Business Officer in Akebia Therapeutics, Inc. ($AKBA) and a SVP, Chief Operating Officer in Akebia Therapeutics, Inc. ($AKBA).

Address: C/O AKEBIA THERAPEUTICS, INC. 245 FIRST STREET, SUITE 1100 CAMBRIDGE 02142 MA

Companies in which Michel Dahan is an Insider

Akebia Therapeutics, Inc.

Trading Symbol: AKBA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michel Dahan: SVP, Chief Operating Officer, SVP, Chief Business Officer
Holdings: 265,550 shares
Current Value: $2,623,634
Latest Transaction: Apr 01 2021
$AKBA Market Capitalization: $177.33M
$AKBA Previous Close: $9.88

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Michel Dahan

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 01 2021AKBAAkebia Therapeutic ...Dahan MichelSVP, Chief Operatin ...SellS3.401,2114,117265,550266.8 K to 265.6 K (-0.45 %)
Mar 18 2021AKBAAkebia Therapeutic ...Dahan MichelSVP, Chief Operatin ...GrantA0.0011,6480266,761255.1 K to 266.8 K (+4.57 %)
Mar 02 2021AKBAAkebia Therapeutic ...Dahan MichelSVP, Chief Operatin ...Option ExerciseA3.46110,000380,600110,000
Mar 02 2021AKBAAkebia Therapeutic ...Dahan MichelSVP, Chief Operatin ...SellS3.407,94526,982255,113263.1 K to 255.1 K (-3.02 %)
Mar 02 2021AKBAAkebia Therapeutic ...Dahan MichelSVP, Chief Operatin ...SellS3.406,60222,421263,058269.7 K to 263.1 K (-2.45 %)
Mar 02 2021AKBAAkebia Therapeutic ...Dahan MichelSVP, Chief Operatin ...GrantA0.0062,0000269,660207.7 K to 269.7 K (+29.86 %)
Mar 02 2020AKBAAkebia Therapeutic ...Dahan MichelSVP, Chief Operatin ...Option ExerciseA8.87120,0001,064,400120,000

View all Michel Dahan insider transactions.